Prognostic Markers of Myelodysplastic Syndromes

Prognostic Markers of Myelodysplastic Syndromes

Myelodysplastic syndrome (MDS) is a clonal disease characterized by multilineage dysplasia, peripheral blood cytopenias, and a high risk of transformation to acute myeloid leukemia. In theory, from clonal hematopoiesis of indeterminate potential to hematologic malignancies, there is a complex interp...

Full description

Bibliographic Details
Main Authors:	Yuliya Andreevna Veryaskina, Sergei Evgenievich Titov, Igor Borisovich Kovynev, Tatiana Ivanovna Pospelova, Igor Fyodorovich Zhimulev
Format:	Article
Language:	English
Published:	MDPI AG 2020-07-01
Series:	Medicina
Subjects:	myelodysplastic syndrome IPSS-R karyotype acute myeloid leukemia microRNA
Online Access:	https://www.mdpi.com/1648-9144/56/8/376

Similar Items

The miRNA Profile in Non-Hodgkin’s Lymphoma Patients with Secondary Myelodysplasia
by: Yuliya Andreevna Veryaskina, et al.
Published: (2020-10-01)

Comparison of Molecular International Prognostic Scoring System (M-IPSS) and Revised International Prognostic Scoring System (R-IPSS) in Thai patients with myelodysplastic neoplasms
by: Chantana Polprasert, et al.
Published: (2022-12-01)

Cytogenetic profile in patients with primary myelodysplastic syndrome
by: S V Gritsaev, et al.
Published: (2013-07-01)

The AST/ALT (De Ritis) ratio as a significant prognostic factor in myelodysplastic syndrome
by: Ying Chen, et al.
Published: (2024-12-01)

Decreased transthyretin predicts a poor prognosis in primary myelodysplastic syndrome
by: Ying Chen, et al.
Published: (2023-03-01)

Elevated serum direct bilirubin is predictive of a poor prognosis for primary myelodysplastic syndrome
by: Ying Chen, et al.
Published: (2024-11-01)

Hyperfibrinogenemia as a Poor Prognostic Indicator in Myelodysplastic Syndrome
by: Shi C, et al.
Published: (2022-06-01)

The Prognostic Value of Pretherapy Peripheral Blood Inflammatory Indices in Myelodysplastic Syndromes
by: Cong Shi, et al.
Published: (2022-04-01)

Cytogenetic profile and risk of transformation to acute myeloid leukemia (AML) in Indonesian patients with myelodysplastic syndrome (MDS): a pilot study [version 1; peer review: 2 approved]
by: Yuniar Harris Prayitno, et al.
Published: (2024-03-01)

The Profile of MicroRNA Expression in Bone Marrow in Non-Hodgkin’s Lymphomas
by: Yuliya A. Veryaskina, et al.
Published: (2022-03-01)

Profiling 25 Bone Marrow microRNAs in Acute Leukemias and Secondary Nonleukemic Hematopoietic Conditions
by: Igor B. Kovynev, et al.
Published: (2020-12-01)

Identifying the similarities and differences between single nucleotide polymorphism array (SNPa) analysis and karyotyping in acute myeloid leukemia and myelodysplastic syndromes
by: Thiago Rodrigo de Noronha, et al.
Published: (2015-02-01)

Complex karyotype in myelodysplastic syndromes: Diagnostic procedure and prognostic susceptibility
by: Mohammad Shahjahani, et al.
Published: (2019-02-01)

Editorial: Immunobiology and immunotherapeutics in myelodysplastic syndrome and acute myeloid leukemia
by: Shyam A. Patel, et al.
Published: (2024-10-01)

Characterisation of Myeloid, Lymphiod and Erythroid Cell Lineages in Myelodysplastics Syndrome Using Flow Cytometry
by: Broojerdi, Mohadese Hashem
Published: (2011)

TP53 mutation in newly diagnosed acute myeloid leukemia and myelodysplastic syndrome
by: Pimjai Niparuck, et al.
Published: (2021-10-01)

Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome
by: Huai-Hsuan Huang, et al.
Published: (2019-06-01)

The Evolving Landscape of Myelodysplastic Syndrome Prognostication
by: Jacob Shreve, et al.
Published: (2020-04-01)

Treatment of Lower Risk Myelodysplastic Syndromes
by: Valeria Santini
Published: (2022-02-01)

Cytogenetic studies of Brazilian pediatric myelodysplastic syndrome cases: challenges and difficulties in a large and emerging country
by: E.D.R.P. Velloso, et al.
Published: (2013-01-01)

Elevated mature monocytes in bone marrow accompanied with a higher IPSS-R score predicts a poor prognosis in myelodysplastic syndromes
by: An Wu, et al.
Published: (2021-05-01)

CLINICAL AND CYTOGENETIC PROFILE IN PATIENTS WITH MYELODYSPLASTIC SYNDROME
by: Muneshwar Kumar, et al.
Published: (2019-06-01)

Venetoclax and Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome: Bursa Uludag University Experience
by: İbrahim Ethem Pınar, et al.
Published: (2021-03-01)

Low Levels of Natural Killer Cell in Newly Diagnosed Myelodysplastic Syndromes Patients May Confer Poor Prognosis: A Retrospective Cohort Study
by: Gong S, et al.
Published: (2024-07-01)

Transformation of a myelodysplastic syndrome to acute myeloid leukemia and concurrent necrotizing sweet syndrome
by: Olga Vera-Lastra, et al.
Published: (2021-03-01)

Cytogenetic Abnormalities in Myelodysplastic Syndromes: An Overview
by: Mohammad Faizan Zahid, et al.
Published: (2016-12-01)

Safety and efficacy of azacitidine in the treatment of elderly patients with myelodysplastic syndrome
by: Ritchie EK
Published: (2012-06-01)

MicroRNA, an Antisense RNA, in Sensing Myeloid Malignancies
by: Stephanie Rebecca Setijono, et al.
Published: (2018-01-01)

Association of loss of heterozygosity with cytogenetic abnormalities in acute myeloid leukemia and myelodysplastic syndrome
by: R.F. Pinheiro, et al.
Published: (2008-07-01)

Association between abnormal lipid profile and inflammation and progression of myelodysplastic syndrome to acute leukemia
by: Wei Qiao, et al.
Published: (2022-09-01)

Difficulties in the differential diagnosis of myelodysplastic syndrome and acute leukemia
by: Alina V. Maltseva, et al.
Published: (2023-05-01)

Relationship between Altered miRNA Expression and DNA Methylation of the DLK1-DIO3 Region in Azacitidine-Treated Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemia with Myelodysplasia-Related Changes
by: Michaela Dostalova Merkerova, et al.
Published: (2018-09-01)

Editorial: Uncovering the relationship between myelodysplastic syndromes and acute myeloid leukemia
by: Mohamed A. Yassin, et al.
Published: (2023-01-01)

Therapy related acute myeloid leukemia with t(10:16): a rare entity
by: Guldeep K. Uppal, et al.
Published: (2011-12-01)

Mutation Analysis of ASXL1 in Normal Karyotype Myelodysplastic Syndromes: Experience From Pakistan
by: Sumera Shaikh, et al.
Published: (2024-12-01)

Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromes
by: Xuefen Yan, et al.
Published: (2021-03-01)

Selinexor in combination with venetoclax and decitabine in patients with refractory myelodysplastic syndrome previously exposed to hypomethylating agents: three case reports
by: Yunshuo Xiao, et al.
Published: (2024-12-01)

Microenvironmental Features Driving Immune Evasion in Myelodysplastic Syndromes and Acute Myeloid Leukemia
by: Georgios Petros Barakos, et al.
Published: (2022-06-01)

Hypomethylating Chemotherapeutic Agents as Therapy for Myelodysplastic Syndromes and Prevention of Acute Myeloid Leukemia
by: Vincent G. Sorrentino, et al.
Published: (2021-07-01)

Laboratory diagnostics stages of myelodysplastic syndrome transformation into acute erythroid leukemia (clinical case report)
by: I. E. Volgina
Published: (2022-01-01)